Curatis Holding AG | WebDisclosure

Basculer en Français

10444	Companies
219257	Keywords
148705	Articles
115974	Press releases

Home
Companies
Curatis Holding AG

PRESS RELEASE

published on 09/15/2025 at 07:00, 8 months 9 days ago

Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01
Curatis Holding AG reports double-digit revenue growth in H1 2025, signing a significant partnership with Phoenix Labs for C-PTBE-01. Financials show a loss due to increased development expenses for corticorelin

Revenue Growth Partnership Financials Curatis Holding AG C-PTBE-01
BRIEF

published on 09/05/2025 at 07:05, 8 months 19 days ago

Curatis va augmenter ses revenus grâce à un partenariat avec Phoenix Labs

Suisse Accord De Distribution Croissance Des Revenus Curatis Laboratoires Phoenix
BRIEF

published on 09/05/2025 at 07:05, 8 months 19 days ago

Curatis to Boost Revenue with Phoenix Labs Partnership

Revenue Growth Distribution Agreement Switzerland Curatis Phoenix Labs
PRESS RELEASE

published on 09/05/2025 at 07:00, 8 months 19 days ago

Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025

Revenue Growth Switzerland Curatis Holding AG Phoenix Labs Distribution Contract
BRIEF

published on 07/31/2025 at 06:05, 9 months 24 days ago

La FDA organise une réunion de type B pour l'essai de phase 3 de Curatis sur la corticoréline

Essai De Phase 3 Curatis Holding AG Réunion De La FDA Corticoréline Traitement PTBE
BRIEF

published on 07/31/2025 at 06:05, 9 months 24 days ago

FDA Schedules Type B Meeting for Curatis' Phase 3 Corticorelin Trial

Phase 3 Trial Curatis Holding AG FDA Meeting Corticorelin PTBE Treatment
PRESS RELEASE

published on 07/31/2025 at 06:00, 9 months 24 days ago

FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients

FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting
BRIEF

published on 05/24/2025 at 11:36, 11 months 30 days ago

Curatis Holding AG's AGM Approves Board's Proposals

Board Of Directors Pharmaceutical Company SIX Swiss Exchange Curatis Holding AG AGM Approval
BRIEF

published on 05/24/2025 at 11:36, 11 months 30 days ago

L'assemblée générale annuelle de Curatis Holding AG approuve les propositions du conseil d'administration

Conseil D'administration SIX Swiss Exchange Curatis Holding AG Approbation De L'AGA Société Pharmaceutique
PRESS RELEASE

published on 05/24/2025 at 11:31, 11 months 30 days ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG shareholders approve all proposals at Annual General Meeting including annual report and 2024 financial year. Details of re-elected board members and company focus on rare diseases

Annual General Meeting Shareholders Financial Year 2024 Rare Diseases Curatis Holding AG

Accesswire

Published on 05/23/2026 at 19:45, 13 hours 36 minutes ago

Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 6 hours ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 6 hours ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 6 hours ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 6 hours ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec

View all ACCESSWIRE

EQS Group

Published on 05/24/2026 at 05:55, 3 hours 26 minutes ago

The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 3 hours 46 minutes ago

CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 16 hours 51 minutes ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 17 hours 24 minutes ago

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 11 hours ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

Les Echos

Published on 05/22/2026 at 19:35, 1 day 13 hours ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 15 hours ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 15 hours ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 20 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE